Late-evening workday botanical beverage

A botanical flavor concept for the end of a workday, with caffeine exposure, taste and processing questions addressed before a formula is selected. Not a substitute for rest.

Where are you starting?

For brand founders, product managers and R&D / procurement teams with an existing formula. Define a reviewable scope first, then confirm executors and a quote.

I have an early idea

Share the audience, occasion, flavor preferences and market direction; budget, packaging and volume can be “to discuss”.

Shape my product idea

I have a formula to transfer

Share nonconfidential format, process stage, packaging and market; describe formula ownership and completed trials. Agree confidentiality and technical handover before sharing a formula, not through this form.

Review formula transfer needs

Proposed stage deliverables

These are discussion outputs, not an accepted R&D or manufacturing commitment; deliverables, executors and fees are agreed in writing per project.

  1. Brief review | direct coordination

    Proposed brief, target market and open-question list, with scope confirmed by the customer.

  2. Ingredient selection | direct coordination

    Proposed candidate-material table, specification/document requests and feasibility questions.

  3. R&D & packaging | executor to confirm

    Proposed prototype and stability protocol, packaging direction and acceptance criteria; qualified R&D, testing and design partners to be reviewed before execution.

  4. Transfer & production | written agreement

    Proposed transfer-gap review, pilot plan, responsibility matrix and delivery-document list; partner line, price, quantity and schedule require confirmation.

Illustrative concepts, not validated formulas, launched products or customer cases; no efficacy, dose or delivery promise. Market eligibility, labeling and safety require separate review.

View packaging concept illustration (not actual goods)
Botanical packaging concepts: green can, ivory tea carton and amber bottle; not actual goods.
Packaging concept / visual direction, not a product photograph, launched range or packaging supply commitment. Wording is provisional design copy requiring trademark and label review.

Occasion & brief

Begin with the occasion, market, intended adult audience and whether any tea-derived caffeine is acceptable. Explore a restrained botanical profile rather than promising wakefulness, recovery or sleep benefits. The initial route can exclude tea if the caffeine brief cannot be met.

Candidate ingredients & trade-offs

Screen a documented low-caffeine green-tea grade only if residual caffeine can be measured and accepted. Reishi is a separate, optional bitter botanical direction, conditional on species, fungal part, local use status and safety review. Neither ingredient is a validated combination or a mandatory formula.

Proposed R&D validation plan

Plan blinded sensory comparisons for bitterness and astringency; measure caffeine in the selected prototype rather than inferring it from a name. Compare pH, turbidity, sediment, color and marker retention before and after the proposed heat cycle. Agree storage conditions, time points and rejection criteria before testing.

Packaging & visual direction

A dark-green can is a visual direction, not a confirmed filling format. Check coating compatibility, seam integrity, oxygen control and the partner's validated process before selection. The name AFTER HOURS is illustrative copy only; trademark and label clearance remain project tasks.

Connect the concept to ingredients & technical reading

Who does what: capability & responsibility boundaries

Direct coordination scope

Brief development, extract selection and procurement-document discussion, grounded in the extract business. Own production, partner supply or custom sourcing must be confirmed per SKU; a listing does not prove in-house manufacture.

Potential partner workstreams

Discuss potential R&D execution, testing, design, packaging-material and filling/manufacturing partners. Selection, qualifications, equipment and contracts require project review; no verified partner capacity is represented here.

Requires project confirmation

An owned R&D lab, filling line, certifications, clinical testing, shelf-life and delivery terms are not verified here. Agree outputs, release responsibility, formula/design ownership, failure costs and shipping terms in writing.

You do not need a finished formula to start

Bring the occasion, market, flavor preferences, exclusions and packaging idea. The next step is a feasibility discussion; do not send confidential formulas through the form.

Discuss this brief →

Literature · materials · boundaries

Research reading cards

Selected literature, not a live feed or systematic review. Editorial check: 2026-09-08; abstract-level reading, not medical or regulatory claim approval.

Shared reading limits: not finished-product efficacy evidence; no dose advice

Ingredient literature is not evidence of efficacy or safety for our extract or any finished product. No clinical validation, disease claim or market authorization is implied.

Review of heterogeneous studies: no single dose, population or duration is established by this card. Individual protocols and full text must be assessed before use. No serving dose is recommended.

Application filters describe reading relevance, not material suitability or local authorization.

2 reviewed entries on this page: Literature review • abstract-level editorial assessment (2)

Literature review • abstract-level editorial assessment · 2023

Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.

EGCG derivatives and stability, not a trial of a commercial green-tea beverage.

Study material, context & sources

Bakun P, Mlynarczyk DT, Koczorowski T, Cerbin-Koczorowska M, Piwowarczyk L, Kolasiński E, Stawny M, Kuźmińska J, Jelińska A, Goslinski T.

PMID: 37776575 · DOI: 10.1016/j.ejmech.2023.115820

Species & study material / specific limits
Camellia sinensis EGCG and chemically modified derivatives; not interchangeable with leaf extract.
Related ingredient science profile →

Literature review • abstract-level editorial assessment · 2024

Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review.

Industrial standardization and composition; biological discussion is not evidence for sleep beverages.

Study material, context & sources

Wu P, Zhang C, Yin Y, Zhang X, Li Q, Yuan L, Sun Y, Zhou S, Ying S, Wu J.

PMID: 39435114 · DOI: 10.1016/j.heliyon.2024.e36987

Species & study material / specific limits
Ganoderma lucidum polysaccharides and triterpenes across heterogeneous materials.
Related ingredient science profile →
All research & editorial method →